Pfizer Inc. (LON:0Q1N)

Market Cap	105.50B
Revenue (ttm)	46.82B
Net Income (ttm)	7.33B
Shares Out	n/a
EPS (ttm)	1.29
PE Ratio	14.39
Forward PE	7.89
Dividend	1.31 (5.38%)
Ex-Dividend Date	Nov 7, 2025

Volume	227,321
Average Volume	178,886
Open	24.56
Previous Close	24.42
Day's Range	24.12 - 24.63
52-Week Range	20.77 - 27.88
Beta	0.47
RSI	44.63
Earnings Date	Nov 4, 2025

About Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral pr...

• Industry: Pharmaceutical Preparations
• Founded: 1849
• Employees: 81,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0Q1N

Financial Performance

In 2024, Pfizer's revenue was $63.63 billion, an increase of 6.84% compared to the previous year's $59.55 billion. Earnings were $8.03 billion, an increase of 279.00%.

Financial numbers in USD